Report Detail
Global and China Blood-Brain Barrier Transport Drugs Market Insights, Forecast to 2026
- RnM4197970 |
- 09 September, 2020 |
- Global |
- 145 Pages |
- QYResearch |
- Pharma & Healthcare
Blood-Brain Barrier Transport Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Blood-Brain Barrier Transport Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Blood-Brain Barrier Transport Drugs market is segmented into
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others
Segment by Application, the Blood-Brain Barrier Transport Drugs market is segmented into
Alzheimer's Disease
Epilepsy
Parkinson's Disease
Multiple Sclerosis
Hunter's Syndrome
Brain Cancer
Others
Regional and Country-level Analysis
The Blood-Brain Barrier Transport Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Blood-Brain Barrier Transport Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Blood-Brain Barrier Transport Drugs Market Share Analysis
Blood-Brain Barrier Transport Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood-Brain Barrier Transport Drugs business, the date to enter into the Blood-Brain Barrier Transport Drugs market, Blood-Brain Barrier Transport Drugs product introduction, recent developments, etc.
The major vendors covered:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics
1 Study Coverage
- 1.1 Blood-Brain Barrier Transport Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Blood-Brain Barrier Transport Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Blood-Brain Barrier Transport Drugs Market Size Growth Rate by Type
- 1.4.2 Carrier-mediated Transport
- 1.4.3 Receptor-mediated Transport
- 1.4.4 Absorptive-mediated Transport
- 1.4.5 Active Efflux Transport
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Blood-Brain Barrier Transport Drugs Market Size Growth Rate by Application
- 1.5.2 Alzheimer's Disease
- 1.5.3 Epilepsy
- 1.5.4 Parkinson's Disease
- 1.5.5 Multiple Sclerosis
- 1.5.6 Hunter's Syndrome
- 1.5.7 Brain Cancer
- 1.5.8 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Blood-Brain Barrier Transport Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Blood-Brain Barrier Transport Drugs Revenue 2015-2026
- 2.1.2 Global Blood-Brain Barrier Transport Drugs Sales 2015-2026
- 2.2 Global Blood-Brain Barrier Transport Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Blood-Brain Barrier Transport Drugs Historical Market Size by Region (2015-2020)
- 2.3.1 Global Blood-Brain Barrier Transport Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Blood-Brain Barrier Transport Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Blood-Brain Barrier Transport Drugs Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Region (2021-2026)
- 2.4.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2021-2026)
3 Global Blood-Brain Barrier Transport Drugs Competitor Landscape by Players
- 3.1 Global Top Blood-Brain Barrier Transport Drugs Sales by Manufacturers
- 3.1.1 Global Blood-Brain Barrier Transport Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Blood-Brain Barrier Transport Drugs Manufacturers by Revenue
- 3.2.1 Global Blood-Brain Barrier Transport Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Blood-Brain Barrier Transport Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Blood-Brain Barrier Transport Drugs Revenue in 2019
- 3.2.5 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Blood-Brain Barrier Transport Drugs Price by Manufacturers
- 3.4 Global Blood-Brain Barrier Transport Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Blood-Brain Barrier Transport Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Blood-Brain Barrier Transport Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Blood-Brain Barrier Transport Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Blood-Brain Barrier Transport Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Blood-Brain Barrier Transport Drugs Sales by Type (2015-2020)
- 4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Type (2015-2020)
- 4.1.3 Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Blood-Brain Barrier Transport Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Blood-Brain Barrier Transport Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Blood-Brain Barrier Transport Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Blood-Brain Barrier Transport Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Blood-Brain Barrier Transport Drugs Sales by Application (2015-2020)
- 5.1.2 Global Blood-Brain Barrier Transport Drugs Revenue by Application (2015-2020)
- 5.1.3 Blood-Brain Barrier Transport Drugs Price by Application (2015-2020)
- 5.2 Blood-Brain Barrier Transport Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 6.1.1 China Blood-Brain Barrier Transport Drugs Sales YoY Growth 2015-2026
- 6.1.2 China Blood-Brain Barrier Transport Drugs Revenue YoY Growth 2015-2026
- 6.1.3 China Blood-Brain Barrier Transport Drugs Market Share in Global Market 2015-2026
- 6.2 China Blood-Brain Barrier Transport Drugs Market Size by Players (International and Local Players)
- 6.2.1 China Top Blood-Brain Barrier Transport Drugs Players by Sales (2015-2020)
- 6.2.2 China Top Blood-Brain Barrier Transport Drugs Players by Revenue (2015-2020)
- 6.3 China Blood-Brain Barrier Transport Drugs Historic Market Review by Type (2015-2020)
- 6.3.1 China Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
- 6.3.2 China Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2015-2020)
- 6.3.3 China Blood-Brain Barrier Transport Drugs Price by Type (2015-2020)
- 6.4 China Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2021-2026)
- 6.4.2 China Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2021-2026)
- 6.4.3 China Blood-Brain Barrier Transport Drugs Price Forecast by Type (2021-2026)
- 6.5 China Blood-Brain Barrier Transport Drugs Historic Market Review by Application (2015-2020)
- 6.5.1 China Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
- 6.5.2 China Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2015-2020)
- 6.5.3 China Blood-Brain Barrier Transport Drugs Price by Application (2015-2020)
- 6.6 China Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2021-2026)
- 6.6.2 China Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2021-2026)
- 6.6.3 China Blood-Brain Barrier Transport Drugs Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 7.2 North America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country
- 7.2.1 North America Blood-Brain Barrier Transport Drugs Sales by Country (2015-2020)
- 7.2.2 North America Blood-Brain Barrier Transport Drugs Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 8.2 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country
- 8.2.1 Europe Blood-Brain Barrier Transport Drugs Sales by Country
- 8.2.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country
- 9.2.1 Asia Pacific Blood-Brain Barrier Transport Drugs Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Blood-Brain Barrier Transport Drugs Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 10.2 Latin America Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country
- 10.2.1 Latin America Blood-Brain Barrier Transport Drugs Sales by Country
- 10.2.2 Latin America Blood-Brain Barrier Transport Drugs Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Blood-Brain Barrier Transport Drugs Sales by Country
- 11.2.2 Middle East and Africa Blood-Brain Barrier Transport Drugs Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Cyclenium
- 12.1.1 Cyclenium Corporation Information
- 12.1.2 Cyclenium Description and Business Overview
- 12.1.3 Cyclenium Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
- 12.1.5 Cyclenium Recent Development
- 12.2 BioAdvance
- 12.2.1 BioAdvance Corporation Information
- 12.2.2 BioAdvance Description and Business Overview
- 12.2.3 BioAdvance Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
- 12.2.5 BioAdvance Recent Development
- 12.3 EIP Pharma
- 12.3.1 EIP Pharma Corporation Information
- 12.3.2 EIP Pharma Description and Business Overview
- 12.3.3 EIP Pharma Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
- 12.3.5 EIP Pharma Recent Development
- 12.4 Bioasis
- 12.4.1 Bioasis Corporation Information
- 12.4.2 Bioasis Description and Business Overview
- 12.4.3 Bioasis Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
- 12.4.5 Bioasis Recent Development
- 12.5 Immune Pharmaceuticals
- 12.5.1 Immune Pharmaceuticals Corporation Information
- 12.5.2 Immune Pharmaceuticals Description and Business Overview
- 12.5.3 Immune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
- 12.5.5 Immune Pharmaceuticals Recent Development
- 12.6 AZ Therapies
- 12.6.1 AZ Therapies Corporation Information
- 12.6.2 AZ Therapies Description and Business Overview
- 12.6.3 AZ Therapies Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
- 12.6.5 AZ Therapies Recent Development
- 12.7 Palobiofarma
- 12.7.1 Palobiofarma Corporation Information
- 12.7.2 Palobiofarma Description and Business Overview
- 12.7.3 Palobiofarma Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
- 12.7.5 Palobiofarma Recent Development
- 12.8 Bach Pharma
- 12.8.1 Bach Pharma Corporation Information
- 12.8.2 Bach Pharma Description and Business Overview
- 12.8.3 Bach Pharma Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
- 12.8.5 Bach Pharma Recent Development
- 12.9 BrainsGate
- 12.9.1 BrainsGate Corporation Information
- 12.9.2 BrainsGate Description and Business Overview
- 12.9.3 BrainsGate Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
- 12.9.5 BrainsGate Recent Development
- 12.10 CarThera
- 12.10.1 CarThera Corporation Information
- 12.10.2 CarThera Description and Business Overview
- 12.10.3 CarThera Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
- 12.10.5 CarThera Recent Development
- 12.11 Cyclenium
- 12.11.1 Cyclenium Corporation Information
- 12.11.2 Cyclenium Description and Business Overview
- 12.11.3 Cyclenium Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
- 12.11.5 Cyclenium Recent Development
- 12.12 Fluorinov Pharma
- 12.12.1 Fluorinov Pharma Corporation Information
- 12.12.2 Fluorinov Pharma Description and Business Overview
- 12.12.3 Fluorinov Pharma Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Fluorinov Pharma Products Offered
- 12.12.5 Fluorinov Pharma Recent Development
- 12.13 Fondazione Telethon
- 12.13.1 Fondazione Telethon Corporation Information
- 12.13.2 Fondazione Telethon Description and Business Overview
- 12.13.3 Fondazione Telethon Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Fondazione Telethon Products Offered
- 12.13.5 Fondazione Telethon Recent Development
- 12.14 Minoryx
- 12.14.1 Minoryx Corporation Information
- 12.14.2 Minoryx Description and Business Overview
- 12.14.3 Minoryx Sales, Revenue and Gross Margin (2015-2020)
- 12.14.4 Minoryx Products Offered
- 12.14.5 Minoryx Recent Development
- 12.15 NewGen Therapeutics
- 12.15.1 NewGen Therapeutics Corporation Information
- 12.15.2 NewGen Therapeutics Description and Business Overview
- 12.15.3 NewGen Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 12.15.4 NewGen Therapeutics Products Offered
- 12.15.5 NewGen Therapeutics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Blood-Brain Barrier Transport Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Blood-Brain Barrier Transport Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Blood-Brain Barrier Transport Drugs. Industry analysis & Market Report on Blood-Brain Barrier Transport Drugs is a syndicated market report, published as Global and China Blood-Brain Barrier Transport Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Blood-Brain Barrier Transport Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
